Диссертация (1140617), страница 20
Текст из файла (страница 20)
Dickson D.W. et al. (1994) Hippocampal sclerosis: a common pathologicalfeature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol115(Berl) 88: 212–221.150. Diener H.C., Putzki N. Lietlinien für Diagnostik und Theraie in der Neurologie,Stutgartt: Georg Thieme Verlag (2005), S. 945-52.151. Dix M.R., Hallpike C.S., Hood J. D. The investigation of vestibular function. BrMed Bull 1956; 12: 131–42.152. Doody R.S.
Current treatments for Alzheimer's disease: cholinesteraseinhibitors. J Clin Psychiatry. 2003;64 Suppl 9:11-7.153. Elias P.K., Elias M.F., Robbins M.A., et al. Blood Pressure-Related CognitiveDecline. Does Age Make a Difference? Hypertension 2004; 44:631-6.154. Erisi M.M., Matthews F., Brayne C., et al. for Neuropathology Group of theMedical Research Council Cognitive Function and Ageing Study (MRC CFAS).Pathological correlates of late-onset dementia in a multicentre, community-basedpopulation in England and Wales. Lancet. 2001;357:169–175.155. Esiri M.M., Wilcock G.K., Morris J.H.
Neuropathological assessment of thelesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry.1997;63:749–753.156. Erkinjunnti T., Inzitari D., Pantoni L., et al. Research criteria for subcorticalvascular dementia in clinical trials. J Neural Tranms Suppl. 2000;59:23–30.157. Erkinjuntti T., Kurz A., Gauthier S, et al. Efficacy of galantamine in probablevascular dementia and Alzheimer's disease combined with cerebrovascular disease: arandomised trial.
Lancet. Apr 13 2002;359(9314):1283-90.158. Essen-Möller E. Suggestions for further improvement of the internationalclassification of mental disorders // Cambridge University Press 1971. 1: 308-311.159. European Dementia Study. European Pentoxifylline Multi-Infarct DementiaStudy. Eur Neurol. 1996;36(5):315-21.160. Farooq M.U., Gorelick P.B. Vascular cognitive impairment. Curr AtherosclerRep. 2013 Jun;15(6):330. doi: 10.1007/s11883-013-0330-z.161. Fazekas F., Kleinert R., Roob G.,et al.
Histopathologic analysis of foci of signalloss on gradient-echo T2*-weighted MR images in patients with spontaneousintracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR116Am J Neuroradiol. 1999;20:637–642.162. Fernando M.S., Simpson J.E., Matthews F., et al. MRC Cognitive Function andAgeing Neuropathology Study Group. White matter lesions in an unselected cohort ofthe elderly: molecular pathology suggests origin from chronic hypoperfusion injury.Stroke.
2006;37:1391–1398.163. Fitzpatrick A.L., Kuller L.H., Ives D.G., et al. Incidence and prevalence ofdementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52: 195–204.164. Fotuhi M., Hachinski V., Whitehouse P.J. Changing perspectives regarding latelife dementia. Nat Rev Neurol. 2009;5:649–658.165. Friedman R.A., Leon A.C. Expanding the black box - depression,antidepressants, and the risk of suicide. N Engl J Med. Jun 7 2007;356(23):2343-6.166.
Furuta A., Ishii N., Nishihara Y., Horie A. Medullary arteries in aging anddementia. Stroke. 1991;22:442–446.167. Gainotti G., Ferraccioli M., Vita M.G., Marra C. Patterns of neuropsychologicalimpairment in MCI patients with small subcortical infarcts or hippocampal atrophy. JInt Neuropsychol Soc.
2008;14:611–619.168. Ganguli M. Epidemiology of dementia. In: Abou-Saleh MT, Katona C,Kumar A,eds. Principles and Practice of Geriatric Psychiatry. 3rd ed. Hoboken, NJ: Wiley;2011: chap 38.169. Goadsby P.J. Pathophysiology of Migraine: A disease of the Brain // Headache /Goadsby P.J., Silberstein S.D. (eds).
Butterworth-Heinemann. 1997. P.5-25.170. Goldberg T.E., Weinberger D.R., Berman K.F., et al, Futher evidence fordementia of the prefronal type in schizophrenia? A controlled study of teaching theWisconsin Card Sorting Test Arch Gen Psychiatry (1987) 44:1008-14.171. vanGoolW.A.,EikelenboomP.ThetwofacesofAlzheimer`sdisease//J.Neurol.-2000.-Vol.247.-P.500-505.172. Gorelick P.B., Nyenhuis D. Understanding and treating vascular cognitiveimpairment.
Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):425-37. doi:10.1212/01.CON.0000429174.29601.de.173. Gorelick P.B., Pantoni L. Advances in vascular cognitive impairment. Stroke.1172013 Feb;44(2):307-8. doi: 10.1161/STROKEAHA.111.000219. Epub 2013 Jan 15.174. Gorelick P.B., Sacco R.L. Stroke risk and prevention: introduction. Stroke.
2010Oct;41(10 Suppl):S2. doi: 10.1161/STROKEAHA.110.598433.175. Gorelick P.B., Scuteri A., Black S.E., et al. Vascular contributions to cognitiveimpairment and dementia: a statement for healthcare professionals from the americanheart association/american stroke association // Stroke. 2011.
Sep;42(9):2672-713.doi: 10.1161/STR.0b013e3182299496. Epub 2011 Jul 21.176. HachinskiV.,ShiftinThinkingAboutDementia//JAMA.2008.Vol.300.№18.P.2172-2173.177. Hachinski V., Bowler J. Vascular dementia. Neurology. 1993. № 43. S. 21592160.178. Hachinski V., Iadekola C., Petersen R.C. et al. National Institute of NerologicalDisorders and Stroke – Canadian Stroke Network Vascular Cognitive ImpairmentHarmonization Standarts. Stroke 2006; 37:2220-2241.179. Hachinski V.C., Lassen N.A., Marshall J. Multi-infarct dementia.
A case ofmental deterioration in the elderly. //Lancet. - 1974. -V.2. -P.207-210.180. Hajjar I., Schumpert J., Hirth V., et al. The impact of the use of statins on theprevalence of dementia and the progression of cognitive impairment. J Gerontol ABiol Sci Med Sci (2002) 57:M414-M418.181.
Harboe E., Tjensvoll A.B., Maroni S., Gøransson L.G., et al.. Neuropsychiatricsyndromes in patients with systemic lupus erythematosus and primary Sjögrensyndrome: a comparative population-based study. Ann Rheum Dis. 2009;68:1541–1546.182. Hart R.G., Halperin J.L. Atrial fibrillation and stroke: concepts andcontroversies.
Stroke 2001; 32:803-808.183. Helvink B., Holroyd S. Buspirone for stereotypic movements in elderly withcognitive impairment. J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):242-4.184. Hulette C., Nochlin D., McKeel D.W., et al. Clinical-neuropathologic findingsin multi-infarct dementia: a report of six autopsied cases. Neurology.
1997;48:668–672.118185. Iadecola C., Zhang F., Niwa K., et al. SOD1 rescues cerebral endothelialdysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci.1999;2:157–161.186. Inzitari D., Erkinjuntti T., Wallin A. et al. Subcortical vascular dementia as aspecific target for clinical trials. //Ann. N.Y. Acad. Sci. -2000. –Vol.903.
–P.510-521.187. Jacob R.G. Panic disorder and the vestibular system. Psychiatr Clin North Am1988;11:361-374.188. Jacob R.G., Furman J.M., Balaban C.D. Psychiatric aspects of vestibulardisorders. In: Baloh R.W., Halmagyi G.M., eds. Disorders of the vestibular system.Oxford: Oxford University Press, 1996;509-528.189. Jacob R.G., Furman J.M., Perel J.M. Panic, phobia, and vestibular dysfunction.In: Yates BJ, Miller AD, editors. Vestibular autonomic regulation. Boca Raton, FL:CRC Press; 1996.
p. 197–226.190. Jeerakathil T., Wolf P.A., Beiser A., et al. Cerebral microbleeds: prevalence andassociations with cardiovascular risk factors in the Framingham Study. Stroke.2004;35:1831–1835.191. Jellinger K.A. Alzheimer disease and cerebrovascular pathology: an update.Neural. Transm.- 2002.-№109(5-6).-P.813-836.192. Jellinger K.A. The enigma of vascular cognitive disorder and vascular dementia.Acta Neuropathol 2007; 113: 349-388.193. Johnston S.C., O'Meara E.S., Manolio T.A.
Cognitive impairment and declineare associated with carotid artery disease in patients without clinically evidentcerebrovascular disease// Ann Intern Med. 2004. № 140. P. 237-247.194. Jordan L.C., Hillis A.E.; Disorders of speech and language: aphasia, apraxia anddysarthria. Curr Opin Neurol. 2006 Dec;19(6):580-5.195. Kalaria R.N., Maestre G.E., Arizaga R., et al. World Federation of NeurologyDementia Research Group. Alzheimer’s disease and vascular dementia in developingcountries: prevalence, management, and risk factors [published correction appears inLancet Neurol. 2008 Oct;7: 867].
Lancet Neurol. 2008;7: 812–826.196. Kalimo H. (Ed.; 2005) Pathology and Genetics: Cerebrovascular Diseases.119Basel, Switzerland: ISN Neuropath Press, 2005:255-259. 15.197. Kendler K.S., Aggen S.H., Knudsen G.P., et al. The structure of genetic andenvironmental risk factors for syndromal and subsyndromal common DSM-IV axis Iand all axis II disorders. Am J Psychiatry.
Jan 2011;168(1):29-39.198. Kilander L., Nyman H., Boberg M. et al. Hypertension is related to cognitiveimpairment: a 20-year follow-up of 999 men. Hypertension 1998; 31:780-6.199. Kim J.S. // Cerebrovasc. Dis. – 2000. – Vol.10, N 6. – P. 471-474.200. Kirsch W., McAuley G., Holshouser B., et al. Serial susceptibility weighted MRImeasures brain iron and microbleeds in dementia. J Alzheimers Dis. 2009;17:599–609.201.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
